Massive Bio uses personalized clinical trial matching technology to reach 100,000 cancer patients.

The use of artificial intelligence (AI) technology has revolutionized various fields, including the healthcare industry. The rapidly developing technology is even more vital in the health sector. It especially affects on issues even in health fields such as cancer. In this context, new treatment methods draw attention. Since it is a difficult process to take part in clinical studies to reach new treatments, companies that want to serve in this field must swim against the ocean. Massive Bio, which set out with the mission of erasing cancer from the map, stands out in this field thanks to the artificial intelligence technology it has developed.

A leader in biotechnology, Massive Bio provides personalized services to cancer patients at the right time and scale by performing comprehensive molecular profiling through Next Generation Sequencing (NGS) testing. When cancer patients enter their information into the system, Massive Bio’s artificial intelligence algorithms match existing clinical studies and guide the patient to the most appropriate treatment.

Complied with HIPAA, GDPR and EU Clinical Trial Regulation Criteria

Patient confidentiality and the protection of personal information are among the most important issues for Massive Bio. Medical information is completely confidential. After patients enter their information into the Massive Bio system, patient reports are filtered and all personal information is encrypted. Then, the data of the patients are matched with clinical trials with the CTMS (Clinical Trial Matching System) system.

The knowledge of the patients helps to gather all the data collection. All work at Massive Bio is conducted in accordance with HIPAA (Health Insurance Portability and Accountability Act), GDPR (General Data Protection Regulation) and EU Clinical Research Regulations.

NLP and Computer Vision Technology

Massive Bio maps clinical trial data from around the world to patient data using a variety of artificial intelligence algorithms, including NLP (Neuro-Linguistic Programming) and computer scanning (Computer Vision). Thanks to Massive Bio’s end-to-end AI technology, patients can reach the most suitable treatment method for them within minutes.

All these features make Massive Bio special, and Masive Bio solves bottlenecks in clinical trials around the world. While conducting it, Massive Bio provides exceptional technology-enabled services and a big data platform for the healthcare industry. The company uses all the technologies. It uses to improve the lives of cancer patients, while also serving hospital networks and pharmaceutical companies.

So, Massive Bio has now reached 65,000 cancer patients in 12 countries. It aims to find the most appropriate treatment methods. It aims spread rapidly to wider geographies and to eliminate this disease from the map.

To sum up, the game industry is one of the most important elements of today. Good image quality, being powerful and extensible are among the most significant features to look for in the games you will play. We can help you in this regard with our sectoral knowledge and extensive connections. For more detailed information on the subject, visit our website. At the same time, you can reach us through our communication channels and review our work through our social media channels (Instagram, Reddit, Twitter, and GitHub).

For more information about all our services, please visit our Lavega Games and Lavega Project website.